PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples

(1) Background: Fine-needle aspiration cytology is often used for the pre-operative diagnosis of melanoma metastases. The diagnosis may not be confidently established based on morphology alone, and immunocytochemistry is mandatory. The choice of the most advantageous immunocytochemical antibodies is...

Full description

Bibliographic Details
Main Authors: Andrea Ronchi, Federica Zito Marino, Elvira Moscarella, Gabriella Brancaccio, Giuseppe Argenziano, Teresa Troiani, Stefania Napolitano, Renato Franco, Immacolata Cozzolino
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/3/646
_version_ 1797446840289853440
author Andrea Ronchi
Federica Zito Marino
Elvira Moscarella
Gabriella Brancaccio
Giuseppe Argenziano
Teresa Troiani
Stefania Napolitano
Renato Franco
Immacolata Cozzolino
author_facet Andrea Ronchi
Federica Zito Marino
Elvira Moscarella
Gabriella Brancaccio
Giuseppe Argenziano
Teresa Troiani
Stefania Napolitano
Renato Franco
Immacolata Cozzolino
author_sort Andrea Ronchi
collection DOAJ
description (1) Background: Fine-needle aspiration cytology is often used for the pre-operative diagnosis of melanoma metastases. The diagnosis may not be confidently established based on morphology alone, and immunocytochemistry is mandatory. The choice of the most advantageous immunocytochemical antibodies is critical, as the sample may be scant, and the presence of pigmented histiocytes may be confounding. However, the diagnostic performance of melanocytic markers in this setting is poorly investigated. Moreover, PRAME (preferentially expressed antigen in melanoma) recently emerged as a novel marker for the diagnosis of melanoma. The current work aimed to evaluate the sensitivity and specificity of PRAME for the diagnosis of melanoma metastases in cytological samples, compared to other melanocytic markers. (2) Methods: PRAME, S100, Melan-A, HMB45 and SOX10 were tested on cell block sections of 48 cases of melanoma metastases diagnosed from cytological samples, and 20 cases of reactive lymphadenopathy. (3) Results: S100 and SOX10 showed the highest sensitivity (100%), while the sensitivity of PRAME was 85.4%. PRAME, Melan-A, SOX10 and HMB45 showed a specificity of 100%, while the specificity of S100 was lower (85%), as it marked some histiocytes. (4) Conclusion: PRAME immunocytochemistry is highly specific for the diagnosis of melanoma metastasis from a cytological sample, but is less sensitive compared with other melanocytic markers.
first_indexed 2024-03-09T13:46:22Z
format Article
id doaj.art-a0bc5b020fdb4847babac0dd6b2433ce
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-09T13:46:22Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-a0bc5b020fdb4847babac0dd6b2433ce2023-11-30T20:59:00ZengMDPI AGDiagnostics2075-44182022-03-0112364610.3390/diagnostics12030646PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological SamplesAndrea Ronchi0Federica Zito Marino1Elvira Moscarella2Gabriella Brancaccio3Giuseppe Argenziano4Teresa Troiani5Stefania Napolitano6Renato Franco7Immacolata Cozzolino8Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Via Luciano Armanni 5, 80100 Naples, ItalyPathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Via Luciano Armanni 5, 80100 Naples, ItalyDermatology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Via Luciano Armanni 5, 80100 Naples, ItalyDermatology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Via Luciano Armanni 5, 80100 Naples, ItalyDermatology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Via Luciano Armanni 5, 80100 Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Via Luciano Armanni 5, 80100 Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Via Luciano Armanni 5, 80100 Naples, ItalyPathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Via Luciano Armanni 5, 80100 Naples, ItalyPathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Via Luciano Armanni 5, 80100 Naples, Italy(1) Background: Fine-needle aspiration cytology is often used for the pre-operative diagnosis of melanoma metastases. The diagnosis may not be confidently established based on morphology alone, and immunocytochemistry is mandatory. The choice of the most advantageous immunocytochemical antibodies is critical, as the sample may be scant, and the presence of pigmented histiocytes may be confounding. However, the diagnostic performance of melanocytic markers in this setting is poorly investigated. Moreover, PRAME (preferentially expressed antigen in melanoma) recently emerged as a novel marker for the diagnosis of melanoma. The current work aimed to evaluate the sensitivity and specificity of PRAME for the diagnosis of melanoma metastases in cytological samples, compared to other melanocytic markers. (2) Methods: PRAME, S100, Melan-A, HMB45 and SOX10 were tested on cell block sections of 48 cases of melanoma metastases diagnosed from cytological samples, and 20 cases of reactive lymphadenopathy. (3) Results: S100 and SOX10 showed the highest sensitivity (100%), while the sensitivity of PRAME was 85.4%. PRAME, Melan-A, SOX10 and HMB45 showed a specificity of 100%, while the specificity of S100 was lower (85%), as it marked some histiocytes. (4) Conclusion: PRAME immunocytochemistry is highly specific for the diagnosis of melanoma metastasis from a cytological sample, but is less sensitive compared with other melanocytic markers.https://www.mdpi.com/2075-4418/12/3/646melanoma metastasisimmunocytochemistrySOX10S100Melan-AHMB45
spellingShingle Andrea Ronchi
Federica Zito Marino
Elvira Moscarella
Gabriella Brancaccio
Giuseppe Argenziano
Teresa Troiani
Stefania Napolitano
Renato Franco
Immacolata Cozzolino
PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples
Diagnostics
melanoma metastasis
immunocytochemistry
SOX10
S100
Melan-A
HMB45
title PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples
title_full PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples
title_fullStr PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples
title_full_unstemmed PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples
title_short PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples
title_sort prame immunocytochemistry for the diagnosis of melanoma metastases in cytological samples
topic melanoma metastasis
immunocytochemistry
SOX10
S100
Melan-A
HMB45
url https://www.mdpi.com/2075-4418/12/3/646
work_keys_str_mv AT andrearonchi prameimmunocytochemistryforthediagnosisofmelanomametastasesincytologicalsamples
AT federicazitomarino prameimmunocytochemistryforthediagnosisofmelanomametastasesincytologicalsamples
AT elviramoscarella prameimmunocytochemistryforthediagnosisofmelanomametastasesincytologicalsamples
AT gabriellabrancaccio prameimmunocytochemistryforthediagnosisofmelanomametastasesincytologicalsamples
AT giuseppeargenziano prameimmunocytochemistryforthediagnosisofmelanomametastasesincytologicalsamples
AT teresatroiani prameimmunocytochemistryforthediagnosisofmelanomametastasesincytologicalsamples
AT stefanianapolitano prameimmunocytochemistryforthediagnosisofmelanomametastasesincytologicalsamples
AT renatofranco prameimmunocytochemistryforthediagnosisofmelanomametastasesincytologicalsamples
AT immacolatacozzolino prameimmunocytochemistryforthediagnosisofmelanomametastasesincytologicalsamples